Navigation

Investiment.io
Financial analysis platform

Abbott Laboratories

ABT โ€ข NYSE

$107.45
โ–ผ1.07 (0.99%)โ€ข REGULAR

Abbott Laboratories

$107.45
โ–ผ1.0%
๐Ÿ“ŠSummary๐Ÿ“‹SEC Filings๐Ÿ‘ฅInsider Trading

๐Ÿ“ˆ Advanced DCF Valuation

Professional-grade discounted cash flow analysis with scenario modeling for ABT

Healthcare โ€ข Medical Devices โ€ข Market Cap: $187,950,302,540.52

Scenario Analysis

Compare different scenarios to understand valuation sensitivity

๐Ÿ”ป-64.4% upside

Conservative Case

$38.68

๐Ÿ“Š-53.1% upside

Base Case

$50.88

๐Ÿ”บ-41.4% upside

Optimistic Case

$63.60

๐Ÿ’ฐMarket Price

Current Price

$108.52

DCF Model & Results

Detailed cash flow projections and valuation analysis

๐Ÿ’ต Enhanced Cash Flow Projections

YearRevenueGrowth %Operating Margin %NOPATCapExFCFPV of FCF
1$46,544,400,000.005.0%18.2%$6,679,963,500.00$2,336,538,750.00$5,728,674,750.00$5,223,527,167.38
2$48,406,176,000.004.0%18.2%$6,947,162,040.00$2,297,239,308.00$6,092,799,132.00$5,065,662,424.01
3$50,100,392,160.003.5%18.2%$7,190,312,711.40$2,253,224,371.77$6,431,629,023.63$4,875,846,930.04
4$51,603,403,924.803.0%18.2%$7,406,022,092.74$2,199,362,897.79$6,747,246,253.88$4,664,072,900.24
5$52,893,489,022.922.5%18.2%$7,591,172,645.06$2,136,354,671.91$7,035,172,218.35$4,434,280,833.59
Terminalโ€”3.0%โ€”โ€”โ€”$109,046,871,046.55$68,732,425,481.20
Enterprise Value$92,995,815,736.46
Net Debt$4,407,000,000.00
Equity Value$88,588,815,736.46
Price per Share$50.88
EV/Revenue (Final Year)1.8x
Terminal Value %73.9%
WACC9.7%

๐Ÿฅ Company Financial Health

Historical Revenue Growth0.9%
Current Operating Margin18.2%
FCF Conversion Rate16.7%
Net Debt/Equity0.00
ROE0.0%
ROIC0.0%
Beta1.20
Interest Coverage0.00
Enhanced DCF data sourced from Financial Modeling Prep (FMP) โ€ข Model incorporates industry best practices and academic research โ€ข Calculations are estimates and should not be used as sole investment advice โ€ข Consult with a financial advisor before making investment decisions